Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4626-4637

  Dedieu, Jean Francois ^a   Vigne, Emmanuelle ^a   Torrent, Christophe ^a   Jullien, Carole ^a   Mahfouz, Irène ^a   Caillaud, Jean Michel ^b   Aubailly, Nathalie ^b   Orsini, Cécile ^a   Guillaume, Jean Marc ^b   Opolon, Paule ^a   Delaère, Pia ^b   Perricaudet, Michel ^a   Yeh, Patrice ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CYTOTOXICITY; EMBRYO; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0030923808     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4626-4637.1997     Document Type: Article

References (62)

1. Babiss, L. E., H. S. Ginsberg, and J. E. Darnell, Jr. 1985. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5:2552-2558.
2. Bandara, L. R., E. W. F. Lam, T. S. Sorensen, M. Zamanian, R. Girling, and N. B. La Thangue. 1994. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf6/7 protein. EMBO J. 13:3104-3114.
3. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
4. Bondesson, M., K. Ohman, M. Mannervik, S. Fan, and G. Aküsjarvi. 1996. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J. Virol. 70:3844-3851.
5. Bridge, E., and G. Ketner. 1989. Redundant control of adenovirus late gene expression by early region 4. J. Virol. 63:631-638.
6. Bridge, E., S. Medghalchi, S. Ubol, M. Leesong, and G. Ketner. 1993. Adenovirus early region 4 and viral DNA synthesis. Virology 193:794-801.
7. Byrnes, A. P., J. E. Rusby, M. J. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neurosciences 66:1015-1024.
8. Chang, L.-S., and T. Shenk. 1990. The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters. J. Virol. 64:2103-2109.
9. Cohen-Tannoudji, M., D. Morello, and C. Babinet. 1992. Unexpected position-dependent expression of H-2 and β2-microglobulin/lacZ transgenes. Mol. Reprod. Dev. 33:149-159.
10. Daï, Y., H. M. Schwarz, D. Gu, W.-W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
11. Dedieu, J.-F. Unpublished data.
12. Dix, I., and K. N. Leppard. 1993. Regulated splicing of adenovirus type 5 E4 transcripts and regulated cytoplasmic accumulation of E4 mRNA. J. Virol. 67:3226-3231.
13. Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473.
14. Engelhardt, J. F., Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenovirus. Nat. Genet. 4:27-34.
15. Fagan, R., K. J. Flint, and N. Jones. 1994. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78:799-811.
16. Falgout, B., and G. Ketner. 1987. Adenovirus early region 4 is required for efficient virus particle assembly. J. Virol. 61:3759-3768.
17. Farrell Jr, R. E. 1993. RNA methodologies: a laboratory guide for isolation and characterisation. Academic Press, London, United Kingdom.
18. Gao, G.-P., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
19. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
20. Goodrum, F. D., T. Shenk, and D. A. Ornelles. 1996. Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J. Virol. 70:6323-6335.
21. Gorziglia, M. I., M. J. Kadan, S. Yei, J. Lim, G. M. Lee, R. Luthra, and B. C. Trapnell. 1996. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70: 4173-4178.
22. Graham, F. L., J. Smiley, W. C. Russel, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
23. Halbert, D. N., J. R. Cutt, and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
24. Helin, K., and E. Harlow. 1994. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J. Virol. 68:5027-5035.
25. Hemstrom, C., K. Nordqvist, U. Pettersson, and A. Virtanen. 1988. Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides. J. Virol. 62:3258-3264.
26. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
27. Huang, M. M., and P. Hearing. 1989. Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J. Virol. 63:2605-2615.
28. Kleinberger, T., and T. Shenk. 1993. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J. Virol. 67:7556-7560.
29. Kozarsky, K. F., D. R. McKinley, L. L. Austin, S. E. Raper, L. D. Stratford-Perricaudet, and J. M. Wilson. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269:13695-13702.
30. Krougliak, V., and F. L. Graham. 1995. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6:1575-1586.
31. Lang, A., V. J. Fincham, and J. A. Wyke. 1993. Factors influencing physiological variations in the activity of the Rous sarcoma virus long terminal repeat. Virology 196:564-575.
32. Leader, D. P., I. Gall, P. Campbell, and A. M. Frischauf. 1986. Isolation and characterisation of cDNA clones from mouse skeletal actin mRNA. DNA 5:235-238.
33. Malone, R. W., M. A. Hickman, K. Urhmann-Bruinsma, T. R. Sih, R. Walzem, D. M. Carlson, and J. S. Powell. 1994. Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J. Biol. Chem. 269: 29903-29907.
34. Moore, M., N. Horikoshi, and T. Shenk. 1996. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 93:11295-11301.
35. Müller, U., T. Kleinberger, and T. Shenk. 1992. Adenovirus E4Orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP1. J. Virol. 66:5867-5878.
36. Nordqvist, K., K. Ohman, and G. Aküsjarvi. 1994. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol. Cell. Biol. 14:437-445.
37. O'Connor, R. J., and P. Hearing. 1994. Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J. Virol. 68:6848-6862.
38. Overbeek, P. A., S.-P. Lai, R. V. Van Quill, and H. Westphal. 1986. Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Science 231:1574-1577.
39. Parker Ponder, K., R. P. Dunbar, D. R. Wilson, G. J. Darlington, and S. L. C. Woo. 1991. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum. Gene Ther. 2:41-52.
40. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
41. Ryden, T. A., M. de Mars, and K. Beemon. 1993. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers. J. Virol. 67:2862-2870.
42. Sandler, A. B., and G. Ketner. 1991. The metabolism of host RNAs in cells infected by an adenovirus E4 mutant. Virology 181:319-326.
43. Sarnow, P., P. Hearing, C. W. Anderson, D. N. Halbert, T. Shenk, and A. J. Levine. 1984. Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J. Virol. 49:692-700.
44. Schaack, J., H. F. Maguire, and A. Siddiqui. 1996. Hepatitis B virus X protein partially substitutes for E1A transcriptional function during adenovirus infection. Virology 216:425-430.
45. Shenk, T. 1996. Adenoviridae: the viruses and their replication, p. 2111-2148. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.) Virology. Raven Press, Philadelphia, Pa.
46. Spergel, J. M., W. Hsu, S. Akira, B. Thimmappaya, T. Kishimoto, and S. Chen-Kiang. 1992. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J. Virol. 66:1021-1030.
47. Stallcup, M. R., and L. D. Washington. 1983. Region-specific initiation of mouse mammary tumor virus RNA synthesis by endogenous RNA polymerase II in preparations of cell nuclei. J. Biol. Chem. 258:2802-2809.
48. Stratford-Perricaudet, L. D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector. J. Clin. Invest. 90:626-630.
49. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
50. van der Vliet, P. C. 1990. Adenovirus DNA replication in vitro, p. 1-29. In P. R. Strauss and S. H. Wilson (ed.), The eukaryotic nucleus, vol. 1. Telford Press, Caldwell, N.J.
51. Varley, A. W., M. G. Coulthard, R. S. Meidell, R. D. Gerard, and R. S. Munford. 1995. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. USA 92:5346-5350.
52. Vigne, E. Unpublished data.
53. Wang, Q., and M. H. Finer. 1995. A packaging cell line for propagation of recombinant adenovirus vector containing two lethal gene-region deletions. Gene Ther. 2:775-783.
54. Weiden, M. D., and H. S. Ginsberg. 1994. Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. USA 91:153-157.
55. Weinberg, D. H., and G. Ketner. 1986. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J. Virol. 57:833-838.
56. Weinberg, D. H., and G. Ketner. 1983. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc. Natl. Acad. Sci. USA 80:5383-5386.
57. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
58. Yang, Y., K. U. Jooss, Q. Su, H. C. Ertl, and J. M. Wilson. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
59. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
60. Yeh, P., J.-F. Dedieu, C. Orsini, E. Vigne, P. Denèfle, and M. Perricaudet. 1996. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70:559-565.
61. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
62. Zijderveld, D. C., F. d'Adda di Fagagna, M. Giacca, H. T. Marc Timmers, and P. van der Vliet. 1994. Stimulation of the adenovirus major late promoter in vitro by transcription factor USF is enhanced by the adenovirus DNA binding protein. J. Virol. 68:8288-8295.